|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/337 | |
| A61K 31/255 | |||
| A61P 35/02 | |||
| A61K 33/24 | |||
| A61K 45/06 |
| (11) | Number of the document | 2249826 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08794507.7 |
| Date of filing the European patent application | 2008-07-15 | |
| (97) | Date of publication of the European application | 2010-11-17 |
| (45) | Date of publication and mention of the grant of the patent | 2016-09-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/008647 |
| Date | 2008-07-15 |
| (87) | Number | WO 2009/113989 |
| Date | 2009-09-17 |
| (30) | Number | Date | Country code |
| 75980 | 2008-03-14 | US | |
| PCT/US2008/0034 | 2008-03-14 | WO |
| (72) |
HAUSHEER, Frederick, H., US
|
| (73) |
BIONUMERIK PHARMACEUTICALS, INC.,
8023 Vantage Drive Suite - Lobby 1, San Antonio, TX 78230,
US
|
| (54) | COMPOSITIONS AND METHODS OF USE OF COMPOUNDS TO INCREASE CANCER PATIENT SURVIVAL TIME |
| COMPOSITIONS AND METHODS OF USE OF COMPOUNDS TO INCREASE CANCER PATIENT SURVIVAL TIME |